Fund Holdings — CAXTON CORP

Total Portfolio Value:
$18.52M
Total Bought:
$1.44M
Total Sold:
$11.22M
Net Transaction:
-$9.78M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Xeris Biopharma Holdings Inc5,641,9205,641,9200$10.49M$13.26M71.57%+$2.76M
Savara Inc.(SVRA)3,313,602353,441-2,960,161$12.53M$1.66M8.97%-$10.86M
Rezolute, Inc.(RZLT)1,318,9671,318,9670$1.74M$1.31M7.07%-$432.0K
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)01,322+1,322$0$628.1K3.39%+$628.1K
Molecular Templates Inc136,866136,8660$865.0K$510.5K2.76%-$354.5K
Berkshire Hathaway Inc DelCL B01,035+1,035$0$369.3K1.99%+$369.3K
Apogee Therapeutics Inc12,4727,353-5,119$265.7K$205.4K1.11%-$60.2K
ABIVAX Société AnonymeADS(ABVX)016,743+16,743$0$179.1K0.97%+$179.1K
Lexeo Therapeutics, Inc.(LXEO)010,319+10,319$0$138.5K0.75%+$138.5K
Harpoon Therapeutics Inc013,176+13,176$0$129.3K0.70%+$129.3K
Compass Therapeutics, Inc.(CMPX)86,77343,465-43,308$170.9K$67.8K0.37%-$103.1K
Allakos Inc49,32924,710-24,619$112.0K$67.5K0.36%-$44.5K
ACLARIS THERAPEUTICS INCCOM(ACRS)19,4730-19,473$133.4K$0—-$133.4K
ELEVATION ONCOLOGY INCCOM21,8130-21,813$14.5K$0—-$14.5K
Page 1 of 1
CAXTON CORP — 13F Holdings — Q4 2023 | TickerTrail